Last week, the Food and Drug Administration (FDA) released a “Drug Safety Communication,” warning that Veozah (fezolinetant), a new medicine to treat hot flashes due to menopause, can cause ...
The once-daily oral drug has been cleared under the Veozah brand name for moderate to severe vasomotor symptoms (commonly known as hot flashes) in menopausal women, becoming a non-hormonal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback